149 related articles for article (PubMed ID: 38290210)
1. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
[No Abstract] [Full Text] [Related]
3. Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma.
Havlínová B; Součková I; Kopřivová K; Doležal J
BMC Res Notes; 2024 May; 17(1):147. PubMed ID: 38783369
[TBL] [Abstract][Full Text] [Related]
4. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
5. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
[No Abstract] [Full Text] [Related]
6. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
7. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
8. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
[No Abstract] [Full Text] [Related]
9. Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer.
Mittica M; Dotto A; Comina M; Teliti M; Monti E; Giusti M
Thyroid Res; 2020; 13():1. PubMed ID: 31938042
[TBL] [Abstract][Full Text] [Related]
10. Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine.
Adamska A; Tomczuk-Bobik P; Popławska-Kita AB; Siewko K; Buczyńska A; Szumowski P; Żukowski Ł; Myśliwiec J; Zbucka-Krętowska M; Adamski M; Krętowski AJ
Endocr Connect; 2021 Oct; 10(10):1283-1290. PubMed ID: 34524978
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.
Giusti M; Mittica M; Comite P; Campana C; Gay S; Mussap M
Endocrine; 2018 Jun; 60(3):516-523. PubMed ID: 29302874
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L
Thyroid; 2012 Mar; 22(3):310-7. PubMed ID: 22313411
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
[TBL] [Abstract][Full Text] [Related]
14. Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life Data.
Duskin-Bitan H; Leibner A; Amitai O; Diker-Cohen T; Hirsch D; Benbassat C; Shimon I; Robenshtok E
Thyroid; 2019 May; 29(5):683-691. PubMed ID: 31084551
[No Abstract] [Full Text] [Related]
15. Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.
Kiyota N; Robinson B; Shah M; Hoff AO; Taylor MH; Li D; Dutcus CE; Lee EK; Kim SB; Tahara M
Thyroid; 2017 Sep; 27(9):1135-1141. PubMed ID: 28665259
[TBL] [Abstract][Full Text] [Related]
16. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
17. Factors Predicting Early Release of Thyroid Cancer Patients from the Isolation Room after Radioiodine-131 Treatment.
Fatima N; Zaman Mu; Zaman A; Zaman U; Tahseen R; Shahid W
Asian Pac J Cancer Prev; 2016; 17(1):125-9. PubMed ID: 26838196
[TBL] [Abstract][Full Text] [Related]
18. Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes.
Kukulska A; Krajewska J; Gawkowska M; Paliczka-Cieslik E; Handkiewicz-Junak D; Kropińska A; Puch Z; Olczyk T; Roskosz J; Jarzab B
Arch Med Sci; 2022; 18(5):1241-1247. PubMed ID: 36160333
[TBL] [Abstract][Full Text] [Related]
19. Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.
Anagnostis P; Florou P; Bosdou JK; Grimbizis GF; Iakovou I; Kolibianakis EM; Goulis DG
Maturitas; 2021 Jun; 148():40-45. PubMed ID: 34024350
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
Chouhan A; Abhyankar A; Basu S
Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]